EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Discovery of a First‐in‐Class Dual‐Function TLX Activator by Microscale Library Synthesis and Direct‐to‐Biology Screening

Tanja Stiller, Romy Busch, Giuseppe Faudone, Felia C. Haffelder, Jan Vietor, Arthur Kardanov, Úrsula López‐García, Arne Hackspacher, Georg Höfner, Vasily Morozov, Susanne F. Koch, Julian A. Marschner und 1 weitere

Angewandte Chemie Novit · 2026-12 · 2 (4)

DOI: 10.1002/anov.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie Novit, online erschienen am 25.10.2026. Verfasst von Tanja Stiller und 12 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Research Council, Deutsche Forschungsgemeinschaft.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tailless homolog (TLX) is a transcription factor with dual transcriptional repressor and activator properties and is thought to govern neural stem cell (NSC) and retinal progenitor cell homeostasis by maintaining a balance of proliferation and differentiation in these unique cell populations. TLX modulation may offer pharmacological control over neurogenesis and retinal cell development with therapeutic potential in degenerative pathologies, but TLX ligands to explore this concept are lacking. Here, we employed an evolution‐inspired ligand development approach with microscale synthesis and direct‐to‐biology testing to obtain potent activators of TLX’s repressor function and its transcriptional activity on the TLX‐activating element (TAE). Ligands promoting TLX's repressor or activator properties differently affected receptor dimerization and coregulator recruitment, providing a molecular basis for TLX modulation. In transcriptomic and phenotypic studies, TAE activation induced cellcycle gene programs and promoted cell cycle entry of terminally differentiated retinal pigment epithelial cells ex vivo, supporting the regenerative potential of TLX agonists.

Förderung

  • European Research Council
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Stiller, T., Busch, R., Faudone, G., Haffelder, F. C., Vietor, J., Kardanov, A., López‐García, Ú., Hackspacher, A., Höfner, G., Morozov, V., Koch, S. F., Marschner, J. A., & Merk, D. (2026). Discovery of a First‐in‐Class Dual‐Function TLX Activator by Microscale Library Synthesis and Direct‐to‐Biology Screening. Angewandte Chemie Novit, 2(4). https://doi.org/10.1002/anov.70039

Vancouver

Stiller T, Busch R, Faudone G, Haffelder FC, Vietor J, Kardanov A, et al. Discovery of a First‐in‐Class Dual‐Function TLX Activator by Microscale Library Synthesis and Direct‐to‐Biology Screening. Angewandte Chemie Novit. 2026;2(4). doi:10.1002/anov.70039

BibTeX
@article{Stiller2026,
  author = {Stiller, Tanja and Busch, Romy and Faudone, Giuseppe and Haffelder, Felia C. and Vietor, Jan and Kardanov, Arthur and López‐García, Úrsula and Hackspacher, Arne and Höfner, Georg and Morozov, Vasily and Koch, Susanne F. and Marschner, Julian A. and Merk, Daniel},
  title = {Discovery of a First‐in‐Class Dual‐Function TLX Activator by Microscale Library Synthesis and Direct‐to‐Biology Screening},
  journal = {Angewandte Chemie Novit},
  year = {2026},
  volume = {2},
  number = {4},
  doi = {10.1002/anov.70039}
}
Kostenlos starten →